Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2022. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 4687856010 | Product containing precisely ipratropium bromide 20 microgram and levosalbutamol (as levosalbutamol sulfate) 50 microgram/1 actuation pressurized conventional release solution for inhalation (clinical drug) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 4687857018 | Ipratropium bromide 20 microgram and levosalbutamol (as levosalbutamol sulfate) 50 microgram/actuation pressurised solution for inhalation | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 4687858011 | Ipratropium bromide 20 microgram and levosalbutamol (as levosalbutamol sulfate) 50 microgram/actuation pressurized solution for inhalation | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 4687861012 | Ipratropium bromide 20 microgram and levalbuterol (as levalbuterol sulfate) 50 microgram/actuation pressurized solution for inhalation | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 4687862017 | Ipratropium bromide 20 microgram and levalbuterol (as levalbuterol sulfate) 50 microgram/actuation pressurised solution for inhalation | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 5301891000052111 | ipratropiumbromid 20 mikrog/dos och levalbuterol (som levalbuterolsulfat) 50 mikrog/dos, inhalationssprej, lösning | sv | Synonym (core metadata concept) | Active | Only initial character case insensitive (core metadata concept) | SNOMED CT Sweden NRC maintained module (core metadata concept) |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Product containing precisely ipratropium bromide 20 microgram and levosalbutamol (as levosalbutamol sulfate) 50 microgram/1 actuation pressurized conventional release solution for inhalation (clinical drug) | Is a | Product containing only ipratropium and levosalbutamol in pulmonary dose form (medicinal product form) | true | Inferred relationship | Some | ||
| Product containing precisely ipratropium bromide 20 microgram and levosalbutamol (as levosalbutamol sulfate) 50 microgram/1 actuation pressurized conventional release solution for inhalation (clinical drug) | Has manufactured dose form | Pressurized conventional release solution for inhalation (dose form) | true | Inferred relationship | Some | ||
| Product containing precisely ipratropium bromide 20 microgram and levosalbutamol (as levosalbutamol sulfate) 50 microgram/1 actuation pressurized conventional release solution for inhalation (clinical drug) | Has unit of presentation | Actuation (unit of presentation) | true | Inferred relationship | Some | ||
| Product containing precisely ipratropium bromide 20 microgram and levosalbutamol (as levosalbutamol sulfate) 50 microgram/1 actuation pressurized conventional release solution for inhalation (clinical drug) | Has precise active ingredient | Levosalbutamol sulfate (substance) | true | Inferred relationship | Some | 1 | |
| Product containing precisely ipratropium bromide 20 microgram and levosalbutamol (as levosalbutamol sulfate) 50 microgram/1 actuation pressurized conventional release solution for inhalation (clinical drug) | Has basis of strength substance (attribute) | Levosalbutamol | true | Inferred relationship | Some | 1 | |
| Product containing precisely ipratropium bromide 20 microgram and levosalbutamol (as levosalbutamol sulfate) 50 microgram/1 actuation pressurized conventional release solution for inhalation (clinical drug) | Has presentation strength numerator unit | mcg | true | Inferred relationship | Some | 1 | |
| Product containing precisely ipratropium bromide 20 microgram and levosalbutamol (as levosalbutamol sulfate) 50 microgram/1 actuation pressurized conventional release solution for inhalation (clinical drug) | Has presentation strength denominator unit (attribute) | Actuation (unit of presentation) | true | Inferred relationship | Some | 1 | |
| Product containing precisely ipratropium bromide 20 microgram and levosalbutamol (as levosalbutamol sulfate) 50 microgram/1 actuation pressurized conventional release solution for inhalation (clinical drug) | Has precise active ingredient | Ipratropium bromide (substance) | true | Inferred relationship | Some | 2 | |
| Product containing precisely ipratropium bromide 20 microgram and levosalbutamol (as levosalbutamol sulfate) 50 microgram/1 actuation pressurized conventional release solution for inhalation (clinical drug) | Has basis of strength substance (attribute) | Ipratropium bromide (substance) | true | Inferred relationship | Some | 2 | |
| Product containing precisely ipratropium bromide 20 microgram and levosalbutamol (as levosalbutamol sulfate) 50 microgram/1 actuation pressurized conventional release solution for inhalation (clinical drug) | Has presentation strength numerator unit | mcg | true | Inferred relationship | Some | 2 | |
| Product containing precisely ipratropium bromide 20 microgram and levosalbutamol (as levosalbutamol sulfate) 50 microgram/1 actuation pressurized conventional release solution for inhalation (clinical drug) | Has presentation strength denominator unit (attribute) | Actuation (unit of presentation) | true | Inferred relationship | Some | 2 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
This concept is not in any reference sets
FHIR